Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2-((diethoxyphosphinyl)thio)-n,n,n,-trimethylethanaminium Iodide
2. Ecothiopate Iodide
3. Ecothiophate Iodide
4. Iodide, Echothiophate
5. Iodide, Ecothiopate
6. Iodide, Ecothiophate
7. Iodide, Phospholine
8. Phospholine Iodide
1. Ecothiopate Iodide
2. 513-10-0
3. Echodide
4. Ecothiophate Iodide
5. Phospholine Iodide
6. Ecothiopati Iodidum
7. Iodure D'ecothiopate
8. Ioduro De Ecotiopato
9. Diethoxyphosphoryl-thiocholine Iodide
10. 217-mi
11. Ecostigmine Iodide
12. Chebi:59849
13. Ethanaminium, 2-((diethoxyphosphinyl)thio)-n,n,n-trimethyl-, Iodide
14. 2-diethoxy-phosphinylthioethyl-trimethylammonium Iodide
15. N-(2-(diethoxyphosphinylthio)ethyl)trimethylammonium Iodide
16. Ecothiopate Iodide [inn]
17. O,o-diethyl S-2-trimethylammonium Ethylphosphonothiolate Iodide
18. Echothiophate Iodide (usp)
19. Echothiophate Iodide [usp]
20. Ba9qh3p00t
21. S-(2-(n,n,n-trimethylammonio)ethyl) O,o-diethylphosphorothiolate Iodide
22. (2-mercaptoethyl)trimethylammonium Iodide S-ester With O,o-diethyl Phosphorothioate
23. Ecostigmini Jodidum
24. 2-diethoxyphosphorylsulfanylethyl(trimethyl)azanium;iodide
25. Phospholine (the Pharmaceutical)
26. Ecothiopati Iodidum [inn-latin]
27. Iodure D'ecothiopate [inn-french]
28. Ioduro De Ecotiopato [inn-spanish]
29. 217 Mi
30. 217mi; Diethoxyphosphinylthiocholine Iodide; Diethylphosphorylthiocholine Iodide; Echothiopate Iodide; Ecostigmini Jodidum;
31. Phospholine Iodide (tn)
32. Einecs 208-152-1
33. Unii-ba9qh3p00t
34. Ethanaminium, 2-[(diethoxyphosphinyl)thio]-n,n,n-trimethyl-, Iodide
35. 2-diaethoxyphosphinyl-thioaethyl-trimethyl-ammonium-jodid [german]
36. Ammonium, (2-(o,o-diethylphosphorothio)ethyl)trimethyl-, Iodide
37. S-(2-dimethylaminoethyl)-o.o-diethylphosphorothioate Methiodide
38. Diethoxyphosphinylthiocholine Iodide
39. Echothiopate Iodide
40. S-ester Of (2-mercaptoethyl)trimethylammonium Iodide With O,o-diethyl Phosphorothioate
41. 2-diaethoxyphosphinyl-thioaethyl-trimethyl-ammonium-jodid
42. Ecothiopateiodide
43. S-beta-dimethylaminoethyl-o,o-diethylthionophosphate Methiodide
44. Ammonium, (2-mercaptoethyl)trimethyl-, Iodide, S-ester With O,o-diethylphosphorothioate
45. Schembl24839
46. Chembl1200367
47. Dtxsid1022976
48. Ecothiopate Iodide [jan]
49. Ecothiopate Iodide (jp17/inn)
50. Echothiophate Iodide [mi]
51. Ecothiopate Iodide [mart.]
52. 2-[(diethoxyphosphinyl)thio]-n,n,n-trimethylethanaminium Iodide
53. Ecothiopate Iodide [who-dd]
54. S-(2-dimethylaminoethyl)-o,o-diethylphosphorothioate Methiodide
55. (2-mercaptoethyl)trimethylammonium Iodidie O,o-diethyl Phosphorothioate
56. 2-[(diethoxyphosphoryl)sulfanyl]-n,n,n-trimethylethanaminium Iodide
57. 2-{[bis(ethyloxy)phosphoryl]thio}-n,n,n-trimethylethanaminium Iodide
58. Bdbm50016940
59. Akos015967621
60. Echothiophate Iodide [orange Book]
61. Hy-16183
62. Echothiophate Iodide [usp Impurity]
63. Echothiophate Iodide [usp Monograph]
64. D02193
Molecular Weight | 383.23 g/mol |
---|---|
Molecular Formula | C9H23INO3PS |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 383.01810 g/mol |
Monoisotopic Mass | 383.01810 g/mol |
Topological Polar Surface Area | 60.8 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 208 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Phospholine iodide |
PubMed Health | Echothiophate Iodide (Into the eye) |
Drug Classes | Antiglaucoma, Miotic, Ophthalmologic Agent |
Active Ingredient | Echothiophate iodide |
Dosage Form | For solution |
Route | Ophthalmic |
Strength | 0.125% |
Market Status | Prescription |
Company | Wyeth Pharms |
2 of 2 | |
---|---|
Drug Name | Phospholine iodide |
PubMed Health | Echothiophate Iodide (Into the eye) |
Drug Classes | Antiglaucoma, Miotic, Ophthalmologic Agent |
Active Ingredient | Echothiophate iodide |
Dosage Form | For solution |
Route | Ophthalmic |
Strength | 0.125% |
Market Status | Prescription |
Company | Wyeth Pharms |
Cholinesterase Inhibitors
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
Miotics
Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)
Parasympathomimetics
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)
Global Sales Information
Market Place
ABOUT THIS PAGE
A Echothiophate Iodide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Echothiophate Iodide, including repackagers and relabelers. The FDA regulates Echothiophate Iodide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Echothiophate Iodide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Echothiophate Iodide supplier is an individual or a company that provides Echothiophate Iodide active pharmaceutical ingredient (API) or Echothiophate Iodide finished formulations upon request. The Echothiophate Iodide suppliers may include Echothiophate Iodide API manufacturers, exporters, distributors and traders.
click here to find a list of Echothiophate Iodide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Echothiophate Iodide DMF (Drug Master File) is a document detailing the whole manufacturing process of Echothiophate Iodide active pharmaceutical ingredient (API) in detail. Different forms of Echothiophate Iodide DMFs exist exist since differing nations have different regulations, such as Echothiophate Iodide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Echothiophate Iodide DMF submitted to regulatory agencies in the US is known as a USDMF. Echothiophate Iodide USDMF includes data on Echothiophate Iodide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Echothiophate Iodide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Echothiophate Iodide suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Echothiophate Iodide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Echothiophate Iodide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Echothiophate Iodide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Echothiophate Iodide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Echothiophate Iodide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Echothiophate Iodide suppliers with NDC on PharmaCompass.
Echothiophate Iodide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Echothiophate Iodide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Echothiophate Iodide GMP manufacturer or Echothiophate Iodide GMP API supplier for your needs.
A Echothiophate Iodide CoA (Certificate of Analysis) is a formal document that attests to Echothiophate Iodide's compliance with Echothiophate Iodide specifications and serves as a tool for batch-level quality control.
Echothiophate Iodide CoA mostly includes findings from lab analyses of a specific batch. For each Echothiophate Iodide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Echothiophate Iodide may be tested according to a variety of international standards, such as European Pharmacopoeia (Echothiophate Iodide EP), Echothiophate Iodide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Echothiophate Iodide USP).
LOOKING FOR A SUPPLIER?